These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17919347)

  • 21. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.
    Mardekian SK; Bombonati A; Palazzo JP
    Hum Pathol; 2016 Mar; 49():114-23. PubMed ID: 26826418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box.
    Lazzeroni M; Dunn BK; Pruneri G; Jereczek-Fossa BA; Orecchia R; Bonanni B; DeCensi A
    Cancer Treat Rev; 2017 Apr; 55():1-9. PubMed ID: 28262606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999.
    Wu X; Chen VW; Ruiz B; Andrews PA; Hsieh MC; Schmidt BA; Correa CN; Fontham ET
    J La State Med Soc; 2003; 155(4):206-13. PubMed ID: 14506828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnosis and management of ductal carcinoma in-situ of the breast.
    Winchester DP; Jeske JM; Goldschmidt RA
    CA Cancer J Clin; 2000; 50(3):184-200. PubMed ID: 10901741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective use of whole breast radiotherapy after breast conserving surgery for invasive breast cancer and DCIS.
    Skandarajah AR; Bruce Mann G
    Surgeon; 2013 Oct; 11(5):278-85. PubMed ID: 23632044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result.
    Alvarado M; Carter DL; Guenther JM; Hagans J; Lei RY; Leonard CE; Manders J; Sing AP; Broder MS; Cherepanov D; Chang E; Eagan M; Hsiao W; Schultz MJ
    J Surg Oncol; 2015 Jun; 111(8):935-40. PubMed ID: 26031501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current perspectives of treatment of ductal carcinoma in situ.
    Estévez LG; Alvarez I; Seguí MÁ; Muñoz M; Margelí M; Miró C; Rubio C; Lluch A; Tusquets I
    Cancer Treat Rev; 2010 Nov; 36(7):507-17. PubMed ID: 20462701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS).
    Cheung S; Booth ME; Kearins O; Dodwell D
    Breast; 2014 Dec; 23(6):807-11. PubMed ID: 25270228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Therapeutic Approaches to DCIS.
    Doke K; Butler S; Mitchell MP
    J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):279-291. PubMed ID: 30267199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ductal carcinoma in situ.
    Bleicher RJ
    Surg Clin North Am; 2013 Apr; 93(2):393-410. PubMed ID: 23464692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K
    Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACR Appropriateness Criteria® Ductal Carcinoma in Situ.
    Kaufman SA; Harris EE; Bailey L; Chadha M; Dutton SC; Freedman GM; Goyal S; Halyard MY; Horst KC; Novick KL; Park CC; Suh WW; Toppmeyer D; Zook J; Haffty BG
    Oncology (Williston Park); 2015 Jun; 29(6):446-58, 460-1. PubMed ID: 26089220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics.
    Schnitt SJ
    J Natl Cancer Inst Monogr; 2010; 2010(41):158-61. PubMed ID: 20956823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.
    Parikh P; Pockaj B; Wasif N; Halyard M; Wong W; Kosiorek HE; Dueck AC; Gray R
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S516-21. PubMed ID: 25986869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
    Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES
    J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
    Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The current clinical value of the DCIS Score.
    Wood WC; Alvarado M; Buchholz DJ; Hyams D; Hwang S; Manders J; Park C; Solin LJ; White J; Willey S
    Oncology (Williston Park); 2014 May; 28 Suppl 2():C2, 1-8, C3. PubMed ID: 25375000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.